These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 517458)

  • 1. Antileukocyte antibodies in patients refractory to platelet transfusions.
    MacPherson BR; Westphal RG
    Am J Clin Pathol; 1979 Dec; 72(6):893-7. PubMed ID: 517458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of HLA and platelet-reactive antibodies in alloimmunized patients refractory to platelet therapy.
    Brubaker DB; Romine M
    Am J Hematol; 1987 Dec; 26(4):341-52. PubMed ID: 3687931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microcapillary agglutination assay for detection of specific antileukocyte reactivity in neutropenic patients.
    Smith WK; Mold JW; Tseng SL; Burton NN
    Am J Hematol; 1979; 7(4):329-40. PubMed ID: 546222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of antibody response to human platelet transfusion.
    Wu KK; Thompson JS; Koepke JA; Hoak JC; Flink R
    J Clin Invest; 1976 Aug; 58(2):432-8. PubMed ID: 956376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed agglutination with platelets.
    Juji T; Kano K; Milgrom F
    Int Arch Allergy Appl Immunol; 1972; 42(3):474-84. PubMed ID: 4553435
    [No Abstract]   [Full Text] [Related]  

  • 6. Alloimmunization to public HLA antigens in multi-transfused platelet recipients.
    MacPherson BR; Hammond PB; Maniscalco CA
    Ann Clin Lab Sci; 1986; 16(1):38-44. PubMed ID: 3947028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experience of HLA-matched platelet transfusion in patients who are refractory to random donor platelets].
    Sekiguchi S; Mitani T; Ohnuma M; Katoh T; Ikeda H; Nakase T; Morioka M; Sakurada K; Miyazaki T
    Hokkaido Igaku Zasshi; 1988 Jul; 63(4):552-61. PubMed ID: 3220437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet transfusion therapy. Optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests.
    Brand A; van Leeuwen A; Eernisse JG; van Rood JJ
    Blood; 1978 May; 51(5):781-8. PubMed ID: 346088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over 95 per cent sensitization against allogeneic leukocytes following single massive blood transfusion.
    Gleichmann H; Breininger J
    Vox Sang; 1975; 28(1):66-73. PubMed ID: 1114788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single donor, HL-A matched platelet transfusions for thrombocytopenic patients undergoing surgery.
    Kahan BD; Green D; Ruder A; Ranney DF; Hartz WH; Mittal KK
    Surgery; 1975 Feb; 77(2):241-8. PubMed ID: 124097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of granulocyte cytotoxins and agglutinins.
    Hasegawa T; Bergh OJ; Terasaki PI; Graw RG
    Transfusion; 1975; 15(3):226-30. PubMed ID: 1129831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension.
    Claas FH; Smeenk RJ; Schmidt R; van Steenbrugge GJ; Eernisse JG
    Exp Hematol; 1981 Jan; 9(1):84-9. PubMed ID: 7238645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies.
    Popovsky MA; Abel MD; Moore SB
    Am Rev Respir Dis; 1983 Jul; 128(1):185-9. PubMed ID: 6603182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antileukocyte and antithrombocyte antibodies in correlation with the incidence of cytotoxic anti-HL-A antibodies in hematologic diseases of various etiology].
    Dinić B; Susaković N
    Bilt Hematol Transfuz; 1976; 4(3):11-6. PubMed ID: 1087555
    [No Abstract]   [Full Text] [Related]  

  • 16. Antileukocyte antibody in postpartum and renal transplant subjects. A comparison of capillary agglutination and lymphocytotoxicity reactions.
    Thompson JS; Jackson D; Greazel NA; Parmely MJ; Severson CD
    Transplantation; 1976 Feb; 21(2):85-93. PubMed ID: 56070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components.
    Eernisse JG; Brand A
    Exp Hematol; 1981 Jan; 9(1):77-83. PubMed ID: 7238644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
    Trial to Reduce Alloimmunization to Platelets Study Group
    N Engl J Med; 1997 Dec; 337(26):1861-9. PubMed ID: 9417523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet transfusion reaction associated with interdonor HLA incompatibility.
    Eastlund DT; McGrath PC; Burkart P
    Vox Sang; 1988; 55(3):157-60. PubMed ID: 3266389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA antibody formation within the HLA-A1 crossreactive group in multitransfused platelet recipients.
    MacPherson BR
    Am J Hematol; 1989 Apr; 30(4):228-32. PubMed ID: 2784623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.